Clinical trial
Immune and Viral Outcomes of HIV-1 Therapy Interruption
NCT00051818 · The Wistar Institute, Other · Completed
Key facts
| NCT number | NCT00051818 |
|---|---|
| Title | Immune and Viral Outcomes of HIV-1 Therapy Interruption |
| Official title | Immune and Viral Outcomes of HIV-1 Therapy Interruption |
| Lead sponsor | The Wistar Institute, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Behavioral |
| Interventions | Treatment interruption/reinitiation schedule |
| Enrollment | 20 |
| Start date | Sep 1, 2000 |
| Primary completion | May 1, 2003 |
| Completion | Jul 1, 2003 |
| First posted | Jan 24, 2003 |
| Last update posted | Feb 9, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: